<DOC>
	<DOC>NCT01101256</DOC>
	<brief_summary>The purpose of this study is to determine residual anticoagulatory effects of a prophylactic or therapeutic fondaparinux treatment i.e. prior to surgery/intervention, after pause of therapy etc.</brief_summary>
	<brief_title>Determination of Residual Anticoagulatory Effects of Fondaparinux</brief_title>
	<detailed_description />
	<mesh_term>Fondaparinux</mesh_term>
	<mesh_term>PENTA</mesh_term>
	<criteria>Fondaparinux therapy for at least 3 days Age &lt; 18 years Hemodialysis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2010</verification_date>
</DOC>